Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 1 53-1, 2003, Pages

  Jones, Steven P ^a   Hoffmeyer, Michaela R ^a   Sharp, Brent R ^a   Ho, Ye Shih ^b   Lefer, David J ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Infarct; Murine; Neutrophils; Oxidants; Oxygen free radicals

Indexed keywords

ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; MANGANESE SUPEROXIDE DISMUTASE; OXYGEN RADICAL;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ENZYME ACTIVITY; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE ISCHEMIA; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0037235033     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00236.2002     Document Type: Article

References (39)

1. Abunasra HJ, Smolenski RT, Morrison K, Yap J, Sheppard MN, O'Brien T, Suzuki K, Jayakumar J, and Yacoub MH. Efficacy of adenoviral gene transfer with manganese superoxide dismutase and endothelial nitric oxide synthase in reducing ischemia and reperfusion injury. Eur J Cardiothorac Surg 20: 153-158, 2001.
2. Ambrosio G, Becker LC, Hutchins GM, Weisman HF, and Weisfeldt ML. Reduction in experimental infarct size by recombinant human superoxide dismutase: Insights into the pathophysiology of reperfusion injury. Circulation 74: 1424-1433, 1986.
3. Braunwald E and Kloner RA. Myocardial reperfusion: A double edged sword. J Clin Invest 76: 1713-1719, 1985.
4. Carrea FP, Lesnefskey EJ, Repine JE, Shikes RH, and Horwitz LD. Reduction of canine myocardial infarct size by a diffusible reactive oxygen metabolite scavenger: Efficacy of dimethylthiourea given at the onset of reperfusion. Circ Res 68: 1652-1659, 1991.
5. Chen EP, Bittner HB, Davis RD, Trigt PV, and Folz RJ. Physiologic effects of extracellular superoxide dismutase transgene overexpression on myocardial function after ischemia and reperfusion injury. J Thorac Cardiovasc Surg 115: 450-459, 1998.
6. Chen Z, Siu B, Ho YS, Vincent R, Chua CC, Hamdy RC, and Chua BHL. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol 30: 2281-2289, 1998.
7. Chi L, Tamura Y, Hoff PT, Macha M, Gallagher KP, Schork MA, and Lucchesi BR. Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 h of regional ischemia and reperfusion: A demonstration of myocardial salvage. Circ Res 64: 665-675, 1989.
8. Engler R and Gilpin E. Can superoxide dismutase alter infarct size? Circulation 79: 1137-1142, 1989.
9. Epstein CJ, Avraham KB, Lovett M, Smith S, Elroy-Stein O, Rotman G, Bry C, and Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome. Proc Natl Acad Sci USA 84: 8044-8048, 1987.
10. Flaherty JT, Pitt B, Gruber JW, Heuser RR, Rothbaum DA, Burwell LR, George BS, Kereiakes DJ, Deitchman D, and Gustafson N. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 89: 1982-1991, 1994.
11. Gallagher KP, Buda AJ, Pace D, Gerren RA, and Shlafer M. Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion. Circulation 73: 1065-1076, 1986.
12. Garlick PB, Davies MJ, Hearse DJ, and Slater TF. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 61: 757-760, 1987.
13. Halliwell B and Gutteridge JMC. Protection against oxidants in biological systems: The superoxide theory of oxygen toxicity. In: Free Radicals in Biology and Medicine, edited by Halliwell B and Gutteridge JMC. Oxford, UK: Clarendon, 1995, p. 86-187.
14. Jolly SR, Kane WJ, Baile MB, Abrams GD, and Lucchesi BR. Canine myocardial reperfusion injury: Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 54: 277-285, 1984.
15. Jones SP, Trocha SD, and Lefer DJ. Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion. Arterioscler Thromb Vasc Biol 21: 2059-2064, 2001.
16. Jones SP, Trocha SD, Strange MB, Granger DN, Kevil CG, Bullard DC, and Lefer DJ. Role of leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 279: H2196-H2201, 2000.
17. Kilgore KS, Friedrichs GS, Johnson CR, Schasteen CS, Riley DP, Weiss RH, Ryan U, and Lucchesi BR. Protective effects of the SOD-mimetic SC-52608 against ischemia/reperfusion damage in the rabbit isolated heart. J Mol Cell Cardiol 26: 995-1006, 1994.
18. Lebovitz RM, Zhang H, Vogel H, Cartwright J, Dionne L, Lu N, Huang S, and Matzuk M. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 93: 9782-9787, 1996.
19. Lefer DJ and Granger DN. Oxidative stress and cardiac disease. Am J Med 109: 315-323, 2000.
20. Li G, Chen Y, Saari JT, and Kang YJ. Catalase-overexpressing transgenic mouse heart is resistant to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 273: H1090-H1095, 1997.
21. Li Q, Bolli R, Qiu Y, Tang XL, Guo Y, and French BA. Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation 103: 1893-1898, 2001.
22. Murohara Y, Yoshiki Y, Hattori R, and Kawai C. Effects of superoxide dismutase on reperfusion arrhythmias and left ventricular function in patients undergoing thrombolysis for anterior wall acute myocardial infarction. Am J Cardiol 67: 765-767, 1991.
23. Naslund U, Haggmark S, Johansson G, Marklund SL, Reiz S, and Oberg A. Superoxide dismutase and catalase reduce infarct size in a porcine myocardial occlusion reperfusion model. J Mol Cell Cardiol 18: 1077-1084, 1986.
24. Nejima J, Knight DR, Fallon JT, Uemura N, Manders T, Canfield DR, Cohen MV, and Vatner SF. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs. Circulation 79: 143-153, 1989.
25. Ooiwa H, Stanley A, Felaneous-Bylund AC, Wilborn W, and Downey JM. Superoxide dismutase conjugated to polyethylene glycol fails to limit myocardial infarct size after 30 min ischemia followed by 72 h of reperfusion in the rabbit. J Mol Cell Cardiol 23: 119-125, 1991.
26. Przyklenk K and Kloner RA. Effect of oxygen-derived free radical scavengers on infarct size following six hours of permanent coronary artery occlusion: Salvage or delay of myocyte necrosis? Basic Res Cardiol 82: 146-158, 1987.
27. Richard VJ, Murry CE, Jennings RB, and Reimer KA. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 min of ischemia in dogs. Circulation 78: 473-480, 1988.
28. Scalia R, Gooszen ME, Jones SP, Hoffmeyer M, Rimmer DM, Trocha SD, Huang PL, Smith MB, Lefer AM, and Lefer DJ. Simvastatin exerts both anti-inflammatory and cardioprotective effects in ApoE deficient mice. Circulation 103: 2598-2603, 2001.
29. Tamura Y, Chi LG, Driscoll EM Jr, Hoff PT, Freeman BA, Gallagher KP, and Lucchesi BR. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion in canine heart. Circ Res 63: 944-959, 1988.
30. Tanaka M, Richard VJ, Murry CE, Jennings RB, and Reimer KA. Superoxide dismutase plus catalase therapy delays neither cell death nor the loss of the TTC reaction in experimental myocardial infarction in dogs. J Mol Cell Cardiol 25: 367-378, 1993.
31. Uraizee A, Reimer KA, Murry CE, and Jennings RB. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation 75: 1237-1248, 1987.
32. Wang P, Chen H, Qin H, Snakarapandi S, Becher MW, Wong PC, and Zweier JL. Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proc Natl Acad Sci USA 95: 4556-4560, 1998.
33. Werns SW, Shea MJ, Mitsos SE, Dysko RC, Fantone JC, Schork A, Abrams GD, Pitt B, and Lucchesi BR. Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart. Circulation 73: 518-524, 1986.
34. Werns SW, Simpson PJ, Mickelson JK, Shea MJ, Pitt B, and Lucchesi BR. Sustained limitation by superoxide dismutase of canine myocardial injury due to regional ischemia followed by reperfusion. J Cardiovasc Pharmacol 11: 36-44, 1988.
35. Yoshida T, Maulik N, Engelman RM, Ho YS, and Das DK. Targeted disruption of the mouse sodI gene makes the hearts vulnerable to ischemic reperfusion injury. Circ Res 86: 264-269, 2000.
36. Yoshida T, Maulik N, Engelman RM, Ho YS, Magnenat JL, Rousou JA, Flack JE, Deaton D, and Das DK. Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation 96, Suppl 9: II216-II220, 1997.
37. Yoshida T, Watanabe M, Engelman DT, Engelman RM, Schley JA, Maulik N, Ho YS, Oberley TD, and Das DK. Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J Mol Cell Cardiol 28: 1759-1767, 1996.
38. Zweier JL. Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J Biol Chem 263: 1353-1357, 1988.
39. Zweier JL, Flaherty JT, and Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 84: 1404-1407, 1987.